CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


TCM prescriptionsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2882 measurement of circulating sFlt1 concentration Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Clinical Trial of TCM Differentiation and Treatment Protocol of COVID-19 in Jiangsu Province

Evaluation of the efficacy and safety of TCM differential treatment of COVID-19 in Jiangsu Province based on the historical prospective multicenter cohort study.

NCT04306497 COVID-19 Drug: TCM prescriptions

Primary Outcomes

Description: comparison of the time of relief / disappearance of three main symptoms of fever, cough and shortness of breath

Measure: The relief of main symptoms/ disappearance rate of time

Time: 9day

Description: with reference to the "pneumonia chest X-ray absorption Evaluation scale" developed by Renyi Yin et al, the final absorption judgment will be used to evaluate the chest CT absorption of patients with pneumonia, which is divided into four levels according to the degree of absorption: complete absorption, majority absorption, partial absorption and no absorption.

Measure: Chest CT absorption

Time: 9day

Secondary Outcomes

Description: With reference to the "Therapeutic effect Standard for diagnosis and Syndrome of Traditional Chinese Medicine" and "guiding principles for Clinical Research of New drugs of traditional Chinese Medicine", the final evaluation was based on clinical remission.

Measure: Evaluation standard of comprehensive curative effect

Time: 9day

Description: the detection negative rate of nasopharyngeal swab, conjunctival sac secretion virus nucleic acid.

Measure: Virus antigen negative conversion rate

Time: 9day

Description: the number of severe and critical cases occurred after the start of intervention.

Measure: The number of severe and critical conversion cases

Time: 9day

Description: defined as complications during isolation and hospitalization due to pneumonia infected by novel coronavirus, including bacterial infection, aggravation of underlying diseases, etc

Measure: Incidence of complications

Time: 9day

Description: According to the Traditional Chinese Medicine symptom score scale, the change of symptom score before and after treatment was observed.The highest score was 92 points, and the lowest was 23 points. The higher the score, the more severe the symptoms.

Measure: Traditional Chinese Medicine Syndrome Score

Time: 9day

Other Outcomes

Description: Changes in c-reactive protein.

Measure: CRP changes

Time: 9day

Description: Changes in erythrocyte sedimentation rate.

Measure: ESR changes

Time: 9day

Description: Changes in procalcitonin.

Measure: PCTchanges

Time: 9day

Description: Changes of CD4+ and CD8+

Measure: The index of T cell subsets changed

Time: 9day


No related HPO nodes (Using clinical trials)